Ariad Pharma (ARIA) Tops Q3 EPS by 7c; Sees Lower Cash Burn
Tweet Send to a Friend
Ariad Pharma (NASDAQ: ARIA) reported Q3 EPS of ($0.36), $0.07 better than the analyst estimate of ($0.43). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
